News

DFDS Reports Mixed Freight Volumes for September Insights

DFDS Reports Mixed Freight Volumes for September Insights

Overview of DFDS September Freight Volumes

In a recent announcement, DFDS shared that the total freight volumes for September showed a slight increase compared to the previous year, hitting 3.5 million lane metres, which is 0.8% higher than the same month in the previous year. When accounting for recent route adjustments, this figure represents a decrease of 1.2%. The year-to-date growth rates indicate a modest increase of 0.2% alongside a more significant adjustment leading to a -1.2% change.

Segment Analysis: Ferry Freight Volumes

When examining specific regions, North Sea volumes remained consistent with last year, boosted by stable traffic across most routes. Conversely, the Mediterranean routes experienced a downturn primarily due to a slowdown in the Turkish automotive sector and diminished domestic demand, coupled with reduced capacity on one route in light of heightened competition. In contrast, volumes in the Channel saw an uptick largely thanks to newly introduced Jersey routes, and both Baltic Sea and Strait of Gibraltar volumes continued to exceed prior year figures.

Yearly Trends in Freight Transport

Over the past twelve months, DFDS reported an overall increase in transported freight lane metres, climbing by 2.3% from 40.7 million to 41.7 million, signifying a stable movement in goods transported within its network. Adjusted for route changes, the growth rate for this period is a more modest 1.2%.

Passenger Volume Insights

On the passenger front, DFDS saw a notable decline in traffic, with September passenger numbers dropping 7.4% to 392,000 compared to the previous year. This decline is also reflected in the adjusted year-to-date growth rate, which stands at -4.1%. Although Baltic Sea routes witnessed a surge in passenger volumes, this was not sufficient to offset the reduced numbers on the Channel routes. Additionally, the number of cars transported fell by 5.7% in the same period.

Long-term Passenger Trends

For the twelve months leading up to the report, total passengers decreased by 14.5%, totaling 5.5 million compared to 6.4 million in the prior year. Even when adjusting for route changes, the growth rate has only modestly improved to 0.4%.

Strategic Adjustments and Future Projections

Several route adjustments have been made which impact these numbers, including the sale of the Oslo-Frederikshavn-Copenhagen route and the strategic exit from Tarifa-Tanger Ville. Meanwhile, new Jersey routes are set to bolster future performance.

DFDS's Commitment to Transparency

DFDS emphasizes its dedication to providing valuable insights into trends within its European route network as a means to facilitate trade and travel across the region. The forthcoming volume report for October is anticipated to be available shortly, offering even more data for analysis.

Contact Information

An open line of communication is maintained for stakeholders, with key personnel available:
Torben Carlsen, CEO +45 33 42 32 01
Karen Boesen, CFO +45 20 58 58 40
Søren Brøndholt Nielsen, IR +45 33 42 33 59
Dennis Kjærsgaard, Media +45 42 30 38 47

About DFDS

Founded in 1866, DFDS operates a comprehensive transport network across Europe, boasting an annual revenue of DKK 30 billion and a dedicated workforce of 16,500 employees. The company specializes in moving goods via ferry, road, and rail, while also providing supplementary transport and logistics solutions. With its headquarters in Copenhagen, DFDS continues to adapt and evolve in a competitive market.

Frequently Asked Questions

What are the key trends in DFDS's freight volumes for September?

The key trends indicate a slight increase of 0.8% in total freight volumes, although this figure drops to 1.2% when adjusted for route changes.

How did passenger numbers fare in September 2025?

DFDS experienced a 7.4% decrease in passenger numbers for September, highlighting challenges particularly in the Channel routes.

What is the long-term trend for DFDS's passenger volumes?

In the past twelve months, total passenger volumes have decreased by 14.5%, indicating significant challenges in maintaining travel demand.

How does DFDS maintain transparency in its operations?

DFDS commits to regular reporting of freight and passenger volumes to provide stakeholders with insights into trends affecting trade and travel.

What adjustments have been made to DFDS's routes recently?

Route modifications include the sale of the Oslo-Frederikshavn-Copenhagen route and exits from less profitable routes, while new Jersey routes have been introduced to enhance future growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading